- Nachrichtendetail
-
05.04.2024 15:46:18 - dpa-AFX: *FDA APPROVES BRISTOL MYERS AND 2SEVENTY BIO'S ABECMA FOR TRIPLE-CLASS EXPOSED R/R MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBBDL-10 | 850501 | Xetra | 37,555 | 31.05.24 17:35:42 | +0,195 | +0,52% | 0,000 | 0,000 | 37,550 | 37,555 |
